Migdal Insurance & Financial Holdings Ltd. Nu Cana PLC Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.74 - $3.27 $2,623 - $11,592	-3,545 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$2.02 - $2.9 $4,316 - $6,197	-2,137 Reduced 37.61%	3,545 $8,000
Q3 2021 Nov 16, 2021	BUY	$1.95 - $2.85 $11,079 - $16,193	5,682 New	5,682 $15,000

Others Institutions Holding NCNA

# of Institutions

Shares Held

3.33M

Call Options Held

Put Options Held

Abingworth LLP London, X0

3.33M
Shares

$4.17 Million
0.73% of portfolio

View Full List

About NuCana plc

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $65.2M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

More about NCNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account